Marked variation in the susceptibility of HIV-1 to type 1 interferon inhibition during early, late and rebound infection

• M. Gondim,
• S. Sherrill-Mix,
• M. Saag,
• M. Nussenzweig,
• J. Silicano,
• P. Sharp,
• P. Borrow,
• L. Montaner,
• K. Bar,
• B. Hahn

Affiliations

M. Gondim

Department of Medicine, University of Pennsylvania, Philadelphia, USA

S. Sherrill-Mix

Department of Medicine, University of Pennsylvania, Philadelphia, USA

M. Saag

Department of Medicine, University of Alabama at Birmingham, Birmingham, USA

M. Nussenzweig

Laboratory of Molecular Immunology, Rockefeller University, New York, USA

J. Silicano

Department of Medicine, Johns Hopkins University, Baltimore, USA

P. Sharp

Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK

P. Borrow

Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK

L. Montaner

Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, USA

K. Bar

Department of Medicine, University of Pennsylvania, Philadelphia, USA

B. Hahn

Department of Medicine, University of Pennsylvania, Philadelphia, USA